Lucarini, G.; Molinelli, E.; Licini, C.; Rizzetto, G.; Radi, G.; Goteri, G.; Mattioli-Belmonte, M.; Offidani, A.; Simonetti, O.
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma. Int. J. Mol. Sci. 2022, 23, 4775.
https://doi.org/10.3390/ijms23094775
AMA Style
Lucarini G, Molinelli E, Licini C, Rizzetto G, Radi G, Goteri G, Mattioli-Belmonte M, Offidani A, Simonetti O.
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma. International Journal of Molecular Sciences. 2022; 23(9):4775.
https://doi.org/10.3390/ijms23094775
Chicago/Turabian Style
Lucarini, Guendalina, Elisa Molinelli, Caterina Licini, Giulio Rizzetto, Giulia Radi, Gaia Goteri, Monica Mattioli-Belmonte, Annamaria Offidani, and Oriana Simonetti.
2022. "Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma" International Journal of Molecular Sciences 23, no. 9: 4775.
https://doi.org/10.3390/ijms23094775
APA Style
Lucarini, G., Molinelli, E., Licini, C., Rizzetto, G., Radi, G., Goteri, G., Mattioli-Belmonte, M., Offidani, A., & Simonetti, O.
(2022). Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma. International Journal of Molecular Sciences, 23(9), 4775.
https://doi.org/10.3390/ijms23094775